Cereona Partners provides capital formation and strategic advisory services to accelerate global health innovation

Science. Strategy. Capital.

Science. Strategy. Capital.

Science. Strategy. Capital. Science. Strategy. Capital.

Cereona Partners is uniquely positioned to liaise between funders, innovators, shareholders, and management. We customize our services to meet your needs.

Services

Placeholder

Strategic Finance: End-to-end finance and capital formation strategy

  • CFO services

  • Financial modeling

  • Deal structuring

Placeholder

Investor Readiness: Full-spectrum preparation across narrative, numbers, and network

  • Pitch deck development

  • Fundraising process advisory

  • Warm investor network

Placeholder

Deal Strategy: Competitive intelligence to design and close the right deals

  • Opportunity sourcing

  • Talent strategy

  • Diligence support

Client Results

  • "Cereona's network and experience across the healthcare industry is quite extensive. They deeply understand the success factors to scale healthcare businesses and can attract the best partners to help in doing so."

    -- Rohit Seth, Founder & Managing Director, Outcomes Collective Growth Capital 

  • “Cereona Partners supports our portfolio with sharp strategic insights—connecting us with aligned partners who add real value. They operate like part of the team.”

    -- Kunal Kain, Founder & Managing Partner, Kain Capital

  • “Cereona Partners was instrumental in helping us exceed our fundraising goals and close an oversubscribed Series B with top-tier investors. This wouldn't have been possible without their industry knowledge, strategic approach, and conviction."

    — CEO, Digital Therapeutics Company

  • "Cereona Partners consistently opens doors to high-quality investors and opportunities across the healthcare ecosystem. Their network, judgment, and diligence expertise make them a trusted partner in every deal.”

    -- Partner, Healthcare Growth Capital Fund

Recent Transactions

Affect Therapeutics

Value: $26m Series B Fundraise
Announced: July 2025

Advisor to Affect Therapeutics on its new Series B investment led by Allumia Ventures, with participation from existing investors Artis Ventures, City Light Capital, and LifeArc Ventures, and new investor Limitless Ventures

Homethrive

Value: $20m+ Series C Fundraise
Announced: November 2024

Investor in Series C round led by TELUS Global Ventures and 7Wire Ventures, with participation from Pitango HealthTech, Human Capital, Outcomes Collective Growth Capital, Allianz, The K Fund, and other family offices.

Insights

Featured
From Sick Care to Smart Care: Aligning Incentives for Prevention
From Sick Care to Smart Care: Aligning Incentives for Prevention

It all begins with an idea.

Read More →
Addiction Treatment is Being Redefined—and So Is the Market
Addiction Treatment is Being Redefined—and So Is the Market

It all begins with an idea.

Read More →
Navigating Healthcare AI: A Guide for Private Equity Investors
Navigating Healthcare AI: A Guide for Private Equity Investors

As healthcare expenditure continues to surge, AI can address challenges across the healthcare continuum.

Read More →

About Cereona Partners

Cereona Partners provides capital formation and strategic advisory services to accelerate global health innovation.

We are partners who have sat in every seat—founder, funder, and builder. This perspective allows us to bridge worlds: we know when to operate within the system and when to take an outside view. Our approach combines creative capital strategy with enduring relationships across companies and investors who are determined to push healthcare forward. At our core, we believe innovation in healthcare is not just about advancing science—it’s about improving humanity.

The name Cereona merges Ceres, the Roman goddess of human flourishing, with Corona, the radiant halo of the sun visible only during an eclipse—the moment when what is normally unseen becomes illuminated. Together, they embody our mission: to illuminate and fund transformative ideas that shape the future of human health.

Team

Opal Joshi

  • Founder & CEO

    Opal is the founder and CEO of Cereona Partners, a strategic advisory firm that bridges science, strategy, and capital to accelerate global health innovation. Opal is a FINRA-registered broker, and is conversational Gujarati, and Spanish. She holds an MBA from The Wharton School at the University of Pennsylvania, and proudly attended The Ohio State University for undergrad.

    Past Experience

    • Leerink Partners – Head of middle market sponsor coverage

    • Novo Holdings – PE buyouts, pharma services and healthcare technology

    • Formation Bio – In-licensing and business development

    • Flatiron Health – Strategic partnerships and JVs

    • Roivant Sciences – In-licensing and commercial development

    Email

  • Partner, Venture Strategy

    Adrianna is a Partner at Cereona Partners, where she helps translate complex science into scalable, investor-backed companies. She specializes in life sciences innovation across preventive health, precision medicine, and AI-driven platforms. Adrianna graduated from McGill University, and is near-native speaker in five languages: English, Portuguese, French, Spanish and, most importantly, Investor.

    Past Experiencess

    • StrandSmart – Founder & CEO Stanford StartX 

    • Qurasense – Co-founder and Bus Dev Lead (Y Combinator & Stanford StartX)

    • Sparkup – Co-founder, business development (acquired 2015)

    Email

  • Director, Operations

    Sophia is the Director of Operations at Cereona Partners. She specializes in translating vision into systems that empower people and processes—aligning teams, removing friction, and creating clarity for scalable execution.

    Past Experience

    • NMBL –  Sr. Project Manager, Creative Ops

    • The Optimus Consultant Group – Director of Operations & HR

    • AI Acrobatics – Sr. Project Manager, AI Systems Design

    • Fenix Consulting Group – Sales & Leadership

    Email

Contact Us